Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors

Por Sacco, Assuntina G, Worden, Francis P
Publicado no Onco Targets Ther (2016)

Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer

Por Acevedo, Joseph R., Fero, Katherine E., Wilson, Bayard, Sacco, Assuntina G., Mell, Loren K., Coffey, Charles S., Murphy, James D.
Publicado no J Clin Oncol (2016)

The Prevalence and Predictive Role of p16 and EGFR in Surgically Treated Oropharyngeal and Oral Cavity Cancer

Por Chandarana, Shamir P., Lee, Julia S., Chanowski, Eric J.P., Sacco, Assuntina G., Bradford, Carol R., Wolf, Gregory T., Prince, Mark E., Moyer, Jeffrey S., Eisbruch, Avraham, Worden, Francis P., Giordano, Thomas J., Kumar, Bhavna, Cordell, Katrina G., Carey, Thomas E., Chepeha, Douglas B.
Publicado em 2012

E6 and E7 antibody levels are potential biomarkers of recurrence in patients with advanced stage human papillomavirus positive oropharyngeal squamous cell carcinoma

Por Spector, Matthew E., Sacco, Assuntina G., Bellile, Emily, Taylor, Jeremy M. G., Jones, Tamara, Sun, Kan, Brown, William C., Birkeland, Andrew C., Bradford, Carol R., Wolf, Gregory T., Prince, Mark E., Moyer, Jeffrey S., Malloy, Kelly, Swiecicki, Paul, Eisbruch, Avraham, McHugh, Jonathan B, Chepeha, Douglas B., Rozek, Laura, Worden, Francis P.
Publicado no Clin Cancer Res (2016)

A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer

Por Swiecicki, Paul L., Bellile, Emily, Sacco, Assuntina G., Pearson, Alexander T., Taylor, Jeremy M. G., Jackson, Trachette L., Chepeha, Douglas B., Spector, Matthew E., Shuman, Andrew, Malloy, Kelly, Moyer, Jeffrey, McKean, Erin, McLean, Scott, Sukari, Ammar, Wolf, Gregory T., Eisbruch, Avraham, Prince, Mark, Bradford, Carol, Carey, Thomas E., Wang, Shaomeng, Nör, Jacques E., Worden, Francis P.
Publicado no Invest New Drugs (2016)